Mother Tincture
Mother tincture of yohimbe bark, used in traditional phytotherapeutic practice.
Tincture
Pausinystalia yohimbe (K. Schum.) Pierre — a West-Central African tree whose bark yields yohimbine, a selective alpha-2 adrenergic antagonist studied for erectile dysfunction, but with well-documented cardiovascular and psychiatric risk that make it one of the more dangerous botanicals in common commercial use.
Pausinystalia yohimbe is a large tree, 20 to 25 meters tall, native to the tropical forests of West-Central Africa (Gabon, Congo, Cameroon). It has oval, pointed leaves (30 x 10 cm) and white flowers with long filiform appendages at the tip of the petals. The trunk bark is the part used medicinally, and yohimbine, its principal active alkaloid, is also available as a synthetic prescription drug (yohimbine hydrochloride).
The aphrodisiac properties of the bark were known to Pygmy peoples of the West-Central African rainforest. Traditionally, bark is stripped from the trunk in large strips, cut, and dried in the sun, and a decoction is then prepared from it as a beverage.
In the West, yohimbine — the bark's principal alkaloid — became a licensed prescription drug for erectile dysfunction well before the modern era of PDE5 inhibitors, and has since become one of the most extensively studied plant alkaloids in psychiatric research, used deliberately to probe noradrenergic function in panic disorder and post-traumatic stress disorder.
A selective alpha-2 adrenergic antagonist, yohimbine is both the compound behind yohimbe's documented effects and the reason for its serious risk profile.
Yohimbine selectively inhibits presynaptic alpha-2 adrenolytic receptors, is sympatholytic, and produces vasodilation and hypotension — the core mechanism behind essentially every documented effect of the plant.
Intravenous yohimbine produced panic attacks meeting DSM-III criteria in 37 of 68 patients with panic disorder or agoraphobia, versus 1 of 20 healthy subjects. [7]
A patient's CYP2D6 enzyme phenotype can explain more than a 20-fold difference in blood yohimbine concentration after the same dose, helping account for unpredictable potency and toxicity between individuals. [19]
Analytical testing of commercial yohimbe and yohimbine dietary supplements found actual yohimbine content frequently does not match what is stated on the label. [18]
The trunk bark is the sole part used, available in traditional and pharmaceutical preparations.
Mother tincture of yohimbe bark, used in traditional phytotherapeutic practice.
Tincture
Synthetic yohimbine hydrochloride, available by prescription and used in most controlled clinical trials.
Prescription Drug
Commercial "specialty" bark-derived supplements — the form most associated with unreliable labeling and severe adverse events.
Herbal Supplement
Documented dosing ranges — read alongside the label-reliability caution below before relying on any figure here for a commercial product.
⚠ Do Not Treat These Doses as Reliable for Commercial Products
Most yohimbe supplement products do not disclose their yohimbine content, and analytical testing has repeatedly found that actual content does not reliably match label claims. [18] Combined with large individual differences in metabolism via the CYP2D6 enzyme, [19] the same labeled dose can produce very different — and unpredictable — effects between products and between people.
Documented phytochemistry of the trunk bark, the sole part with a described composition in the primary source.
Vasodilation of the corpus cavernosum producing rapid erection, with increased duration, endurance and libido.
Selective inhibitor of presynaptic alpha-2 adrenolytic receptors, sympatholytic in action.
Hypertensive at low doses and hypotensive at high doses, with peripheral vasodilator activity.
Activates alpha-adrenergic receptors on adipocytes, reflecting increased lipolysis in laboratory studies. [9][11]
Reliably induces panic attacks meeting clinical diagnostic criteria in panic disorder patients; used deliberately as a pharmacological research probe. [6][7]
Exaggerated behavioral, cardiovascular and catecholamine responses documented in combat veterans with PTSD, including flashbacks. [8]
Documented lipolytic activity has not translated into consistent clinical weight-loss results across randomized trials. [12][14]
A meta-analysis of 7 randomized trials (419 patients) found evidence of efficacy for erectile dysfunction. [1]
Documented uses, including one the primary source itself flags as often negative and one that is a research tool rather than a treatment.
The documented mechanisms behind yohimbine's vascular, sexual and neuropsychiatric effects.
Yohimbine is a selective inhibitor of presynaptic alpha2-adrenolytic receptors, sympatholytic, vasodilator and hypotensive in its overall pharmacological profile.
Produces accentuated vasodilation in the genital organs and increases excitability of the genital organs in the sacral zone.
Blockade of the alpha-2 adrenergic autoreceptor increases release of endogenous norepinephrine in the central nervous system, the mechanism behind its anxiogenic and panicogenic effects in susceptible individuals. [6]
Individual CYP2D6 enzyme phenotype substantially alters yohimbine blood concentration after an identical dose, explaining much of the unpredictability in both effect and toxicity. [19]
Yohimbe carries a genuinely serious risk profile — this section should be read in full before use.
This monograph draws on the primary botanical source plus substantial additional peer-reviewed literature, given the brevity of the original entry — every added claim is linked to a verifiable, named source below.